Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02351700 · ClinicalTrials.gov registry record · Phase 4
Analgesia Regimens Following Trans-sphenoidal Surgery for Pituitary Tumors
A Phase 4 study, sponsored by St. Joseph's Hospital and Medical Center, Phoenix.
- Completed
- Registry status
- Phase 4
- Development phase
- 62
- Enrollment target
NCT02351700 is a Phase 4 study that has completed, run by St. Joseph's Hospital and Medical Center, Phoenix. The registered enrollment target is 62 participants.
The verdict
NCT02351700, a Phase 4 study, has completed, sponsored by St. Joseph's Hospital and Medical Center, Phoenix.
- COMPLETED
- Registry status
- Phase 4
- Development phase
- 62 participants
- Enrollment target
Study Summary
A randomized, double-blind, placebo-controlled intervention trial involving 100 treated subjects undergoing endonasal trans-sphenoidal (ENTS) resection of pituitary lesion. Subjects will be randomized into two groups: 50 treated in the opioid-sparing arm and 50 treated in the standard post-operative medication arm.
Interventions
- DRUG IV Placebo
- DRUG IV Caldolor
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 62 participants |
| Start Date | 2015-02-01 |
| Est. Completion | 2016-04-01 |
| Phase | Phase 4 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02351700
The ClinicalTrials.gov registry entry for NCT02351700 describes a study currently listed as completed, categorized as Phase 4. The registered enrollment target is 62 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is St. Joseph's Hospital and Medical Center, Phoenix, which has 44 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which IV Placebo is the first listed.
NCT02351700 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02351700 about?
NCT02351700 is a clinical study titled "Analgesia Regimens Following Trans-sphenoidal Surgery for Pituitary Tumors". A randomized, double-blind, placebo-controlled intervention trial involving 100 treated subjects undergoing endonasal trans-sphenoidal (ENTS) resection of pituitary lesion. Subjects will be randomized into two groups: 50 treated in the opioid-sparing arm and 50 treated in the standard post-operative...
What is the current status of trial NCT02351700?
This trial is currently completed. It is a Phase 4 study. The enrollment target is 62 participants. The study started on 2015-02-01. Estimated completion is 2016-04-01.
What interventions are being tested in trial NCT02351700?
The interventions under investigation include: IV Placebo (DRUG), IV Caldolor (DRUG).
Who is sponsoring clinical trial NCT02351700?
This trial is sponsored by St. Joseph's Hospital and Medical Center, Phoenix, which has 44 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.